Figure 3. Antitumor effect of miR-143#12 in a mouse cancer model. (IMAGE)
Caption
(Upper left) Change in tumor size over time after miR-143#12 administration, with less increase in size for the miR-143#12-treated group compared to the control group. (Bottom left) Suppression of KRAS signaling network protein expression in tumor samples of the miR-143#12-treated group. (Right) CD31 staining revealing enhanced angiogenesis in the miR-143#12-treated group.
Credit
Gifu University
Usage Restrictions
Credit must be given to the creator.
License
CC BY